Altshuler Shaham LTD Vbi Vaccines Inc Transaction History

Altshuler Shaham LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$0.73 - $1.91 $669,893 - $1.75 Million	-917,662 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$0.65 - $2.12 $187,608 - $611,893	-288,629 Reduced 23.93%	917,662 $1.07 Million
Q1 2019 May 15, 2019	BUY	$1.54 - $2.01 $486,673 - $635,204	316,022 Added 35.5%	1,206,291 $2.26 Million
Q4 2018 Feb 11, 2019	SELL	$1.22 - $2.41 $1,431 - $2,826	-1,173 Reduced 0.13%	890,269 $1.43 Million
Q2 2018 Aug 13, 2018	BUY	$2.75 - $3.85 $252,450 - $353,430	91,800 Added 11.48%	891,442 $2.45 Million
Q1 2018 May 15, 2018	SELL	$3.5 - $4.47 $1,253 - $1,600	-358 Reduced 0.04%	799,642 $2.8 Million
Q4 2017 May 14, 2018	BUY	$3.29 - $5.03 $2.63 Million - $4.02 Million	800,000	800,000 $3.42 Million

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.